A prospective randomized study comparing PVP, CVP with ThuVAP

A prospective randomized study comparing PVP, CVP with ThuVAP - Analysis of the vaporization treatment for BPH

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000038914

Enrollment

100

Registered

2019-12-18

Start date

2019-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia

Interventions

PVP CVP ThuVAP

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: IPSS>7 QOL>1 prostatic volume>20

Exclusion criteria

Exclusion criteria: prostate cancer After surgery for BPH

Design outcomes

Primary

Measure	Time frame
operation time, temperature and therapeutic effect of symptom.	—

Countries

Japan

Contacts

Public ContactDejima Takashi

Kyushu Central Hospital of the Mutual Aid Association of Public School Teachers Department of Urology

dejima@uro.med.kyushu-uac.jp092-541-4936

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026